Dolutegravir 25 mg and 50 mg and Sinequan (Doxepin Capsules)
Determining the interaction of Dolutegravir 25 mg and 50 mg and Sinequan (Doxepin Capsules) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dolutegravir
Brand name: Tivicay
Synonyms: Dolutegravir
Generic Name: doxepin
Brand name: Sinequan, Sinequan, Silenor
Synonyms: Sinequan Capsules, Sinequan
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dolutegravir 25 mg and 50 mg-Sinequan (Doxepin Oral Concentrate)
- Dolutegravir 25 mg and 50 mg-Sinex Long-Acting
- Dolutegravir 25 mg and 50 mg-Sinex Nasal Spray
- Dolutegravir 25 mg and 50 mg-Singulair
- Dolutegravir 25 mg and 50 mg-Singulair (Montelukast Chewable Tablets)
- Dolutegravir 25 mg and 50 mg-Singulair (Montelukast Oral Granules)
- Sinequan (Doxepin Capsules)-Dolutegravir and lamivudine
- Sinequan (Doxepin Capsules)-Dolutegravir and rilpivirine
- Sinequan (Doxepin Capsules)-Dolutegravir Sodium
- Sinequan (Doxepin Capsules)-Dolutegravir Sodium And Lamivudine
- Sinequan (Doxepin Capsules)-Dolutegravir Sodium and Rilpivirine Hydrochloride
- Sinequan (Doxepin Capsules)-Dom-Etoposide